Official UK procurement notice
Antipsychotic Medication Reviews · UK public procurement notice
Authority: NHS Devon Integrated Care Board (Central government)
What is being bought
Published requirement descriptionProvision of an antipsychotic prescribing and drug safety monitoring service for patients registered with a GP in Devon
CPV: Psychiatrist or psychologist services
The lotProcurement structure
single lot · no lot value publishedLot #1The primary aim of this service is to provide ongoing prescribing of antipsychotic…Awarded
The primary aim of this service is to provide ongoing prescribing of antipsychotic medications and drug safety monitoring for patients across NHS Devon with an initial requirement for up to 120 patients. The provider will:
- Ensure ongoing drug safety monitoring and prescribing including appropriate blood tests and ECGs and informed by NICE guidelines
- Ensure that any concerns related to the person's mental health are appropriately escalated to the secondary mental health provider.
- Issue prescription that will be dispended by the patient's local pharmacy.
It is anticipated that after an initial review, 1-2 months prescription lengths would be required, with a 12 month annual review. However, the provider must use clinical judgement, informed by NICE guidance, to determine the physical health monitoring needs of the individual and safe length of prescription.
The ICB envisages care being delivered as close to home as possible, however this could include the service being delivered remotely, with the preferred remote method of contact being agreed with the patient. Where the service is delivered remotely it is anticipated that the primary method will be via Teams (or an equivalent system for safe virtual delivery) and the provider will take reasonable steps to support the patient in the utilisation of IT where advice and guidance may be required e.g. easy to read, jargon free instructions. Should digital poverty or IT connectivity prevent use of virtual delivery, the provider needs to have mitigations available.
This notice is an intention to award a contract under the Provider Selection Regime Most Suitable Provider process.
This is a new service and the award is to an existing contracted provider
The contract term is for a period 12 months. The cost of the service will be based on activity with an anticipated annual cost of approximately £945 per patient where a face to face consultation is required and £645 per patient where a virtual consultation is undertaken. There maybe additional costs payable for diagnostic tests
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 13 Oct 2025, 12:32 BST
- Last source update
- 13 Oct 2025, 12:32 BST
- Authority reference
QJK-24_APMR- FTS notice number
2025/S 000-064712- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05ae2eFind a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period.
Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.'
Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by 23 October 2025. This contract has not yet been formally awarded; this notice serves as an intention to award under PSR. Notices previously published on Find A Tender in relation to this award: 2025/S 000-052253 29 August 2025 2025/S 000-047397 08 August 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| RTN Medical Ltd | £0 † | — | Awarded |
Contracts
Antipsychotic Medication Reviews · RTN Medical Ltd
- Signed
- 13 Oct 2025
- Value
- £0
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS Devon ICBReview body
Bidders & participating suppliers
1 commercial party on the notice- RTN Medical LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.